In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis

Pharmacology and Therapeutics

Volumn 75, Issue 1, 1997, Pages 51-68

  Hadoke, Patrick W F ^a   Hayes, Peter C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cirrhosis; Hyporesponsiveness; Isolated vessels; Vasoconstriction

Indexed keywords

NITRIC OXIDE;

AORTA; ARTICLE; BILE DUCT LIGATION; BLOOD VESSEL REACTIVITY; HEMODYNAMICS; HEPATIC ARTERY; LIVER CIRRHOSIS; PATHOGENESIS; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; VEIN LIGATION;

EID: 0030825621     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(97)00022-3     Document Type: Review

References (169)

1. Aalkjaer, C., Johanssen, P., Pedersen, E. B., Rasmussen, A. and Mulvany, M. J. (1984) Morphology and angiotensin II responses of isolated resistance vessels from patients with pre-eclampsia. Scand. J. Lab. Clin. Invest. 44 (Suppl. 169): 57-60.
2. Aalkjaer, C., Heagerty, A. M., Peterson, K. K., Swales, J. D. and Mulvany, M. J. (1987) Evidence for increased media thickness, increased neuronal amine uptake and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ. Res. 61: 181-186.
3. Aguilera, G. and Catt, K. (1981) Regulation of vascular angiotensin II receptors in the rat during altered sodium intake. Circ. Res. 49: 751-758.
4. Ames, R. P., Borkowski, J., Sickinski, A. M. and Laragh, J. H. (1965) Prolonged infusions of angiotensin II and noradrenaline and blood pressure, electrolyte balance, and aldosterone and corticol secretion in normal man and in cirrhosis with ascites. J. Clin. Invest. 44: 1171-1186.
5. Atucha, N. M., Ortiz, M. C., Martinez, C., Quesada, T. and Garcia-Estan, J. (1996) Role of protein kinase C in mesenteric pressor responses of rats with portal hypertension. Br. J. Pharmacol. 118: 277-282.
6. Badalamenti, S., Graziai, G., Salerno, F. and Ponticelli, C. (1993) Hepatorenal syndrome. New perspectives in pathogenesis and treatment. Arch. Int. Med. 153: 1957-1967.
7. Bader, H. (1963) The anatomy and physiology of the vascular wall. In: Handbook of Physiology. Circulation, Vol. II, Ch. 26, pp. 865-889, Hamilton, W. F. and Dow, P. (eds.) American Physiology Society, Washington.
8. Battaglia, S. E., Jones, R. M., Angus, J. A., Smallwood, R. A. and Angus, P. W. (1996) Altered acetylcholine responsiveness in human cirrhotic intrahepatic arteries. Hepatology 24: 143A.
9. Benjamin, N., Calver, A., Collier, J., Robinson, B., Vallance, P. and Webb, D. (1995) Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 25: 918-923.
10. Benoit, J. N., Wocmack, W. A., Hernandez, L. and Granger, D. N. (1985) 'Forward' and 'backward' flow mechanisms of portal hypertension. Gastroenterology 89: 1096-1099.
11. Benoit, J. N., Zimmerman, B. and Premen, A. J. (1986) Role of glucagon in splanchnic hyperaemia of chronic portal hypertension. Am. J. Physiol. 251: G674-G677.
12. Better, O. S. and Bomzon, A. (1988) Effects of jaundice on the renal and cardiovascular systems. In: The Kidney in Liver Disease, 3rd edn., Ch. 23, pp. 508-536, Epstein, M. (ed.) Williams and Wilkins, Baltimore.
13. Bhathal, P. S. and Grossman, H. J. (1985) Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J. Hepatol. 1: 325-337.
14. Bird, G., Severn, A., Danesh, B. J. and Liew, F. Y. (1993) Nitric oxide in alcohol-induced liver failure. J. Hepatol. 19: 316.
15. Blendis, L., Orrego, H., Crossley, I., Blake, J., Israel, Y. and Orrego, H. (1982) The role of hepatocyte enlargement in hepatic pressure in cirrhotic and non-cirrhotic alcoholic liver disease. Hepatology 2: 539-546.
16. Bomzon, A. (1990) Cardiovascular reactivity in liver disease. In: Cardiovascular Complications of Liver Disease, Ch. 10, pp. 207-223, Bomzon, A. and Blendis, L. M. (eds.) CRC Press, Boca Raton.
17. Bomzon, A. and Blendis, L. M. (1987) Vascular reactivity in experimental portal hypertension. Am. J. Physiol. 252 (Gastrointest. Liver Physiol. 15): G158-G162.
18. Bomzon, A. and Blendis, L. M. (1990) Animal models of liver disease. In: Cardiovascular Complications of Liver Disease, Ch. 1, pp. 9-28, Bomzon A. and Blendis L. M. (eds.) CRC Press, Boca Raton.
19. Bomzon, A. and Blendis, L. M. (1994) The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 20: 1343-1350.
20. Bomzon, A., Finberg, J. P. M., Tovbin, D., Naidu, S. G. and Better, O. S. (1984) Bile salts, hypotension and obstructive jaundice. Clin. Sci. 67: 177-183.
21. Bomzon, A., Gali, D., Better, O. S. and Blendis, L. M. (1985) Reversible suppression of the vascular contractile response in rats with obstructive jaundice. J. Lab. Clin. Med. 105: 568-572.
22. Bomzon, A., Binah, O. and Blendis, L. M. (1988) Temporal changes in pressor and contractile responsiveness in the conscious chronic bile duct ligated (CBDL) dog. Hepatology 8: 1393.
23. Bomzon, A., Jacob, G., Lee, S. S. and Meddings, J. (1991) In vitro vascular responsiveness to norepinephrine in experimental portal hypertension. Clin. Invest. Med. 14: 63-71.
24. Bomzon, A., Binah, O. and Blendis, L. M. (1993) Hypotension in experimental cirrhosis. Is loss of vascular responsiveness to norepinephrine the cause of hypotension in chronic bile-ductligated dogs? J. Hepatol. 17: 116-123.
25. Bomzon, L., Wilton, P. B. and McCalden, T. A. (1978) Impaired skeletal muscle vasomotor reserve to infused noradrenaline in baboons with obstructive jaundice. Clin. Sci. Mol. Med. 55: 109-112.
26. Booth, R. F. G., Martin, J. F., Honey, A. C., Hassal, D. G., Beesley, J. E. and Moncada, S. (1989) Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 76: 275-288.
27. Bosch, J., Gines, P., Arroyo, V., Navasa, M. and Rodes, J. (1988) Hepatic and systemic haemodynamics and the neurohumoural systems in cirrhosis. In: The Kidney in Liver Disease, 3rd edn., Ch. 11, pp. 265-285, Epstein, M. (ed.) Williams and Williams, Baltimore.
28. Braillon, A., Cailmail, S., Gaudin, C. and Lebrec, D. (1993) Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis. J. Hepatol. 17: 86-90.
29. Cahill, P. A., Wu, Y. and Sitzmann, J. V. (1994) Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits. J. Clin. Invest. 93: 2691-2700.
30. Cahill, P. A., Foster, C., Redmond, E. M., Gingalewski, C., Wu, Y. and Sitzman, J. V. (1995) Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology 22: 598-606.
31. Cahill, P. A., Hou, M-C., Zhang, S., Redmond, E. M. and Sitzmann, J. V. (1996a) Increased expression of endothelin receptors in hyperemic vessels from portal hypertensive rats. Hepatology 24: 317A.
32. Cahill, P. A., Redmond, E. M., Wu, Y. and Sitzmann, J. V. (1996b) Regulation of atrial natriuretic factor receptors in portal hypertensive rabbits. J. Hepatol. 24: 185-193.
33. Cailmail, S., Moreau, R., Gadano, A., Tazi, K. A. and Lebrec, D. (1995) The role of calcium channel inhibition in in vitro vascular hyporeactivity to endothelin-1 (ET-1) in rats with cirrhosis. Hepatology 22: 258A.
34. Calver, A., Harris, A., Maxwell, J. D. and Vallance, P. (1994) Effect of local inhibition of nitric oxide synthesis on forearm blood flow and dorsal hand vein size in patients with alcoholic cirrhosis. Clin. Sci. 86: 203-208.
35. Campillo, B., Chabrier, P-E., Pelle, G., Sediame, S., Atlan, G., Fouet, P. and Adnot, S. (1995) Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 22: 1423-1429.
36. Casadevall, M., Pique, J. P., Cirera, I., Goldin, E., Elizalde, I., Panes, J., Martinez-Cuesta, M. A., Bosch, J., Teres, J. and Rodes, J. (1996) Increased blood haemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation. Gastroenterology 110: 1156-1165.
37. Castro, A., Jimenez, W., Claria, J., Ros, J., Martinez, J. M., Bosch, M., Arroyo, V., Piulats, J., Rivera, F. and Rodes, J. (1993) Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology 18: 367-372.
38. Castro, A., Ros, J., Jimemez, W., Claria, J., Libre, J., Leivas, A., Arroyo, V., Rivera, F. and Rodes, J. (1994) Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis. J. Hepatol. 21: 521-526.
39. Cawley, T., Geraghty, J., Osborne, H. and Docherty, J. R. (1995) Effects of portal hypertension on responsiveness of rat mesenteric artery and aorta. Br. J. Pharmacol. 114: 791-796.
40. Champigneulle, B., Braillon, A., Kleber, G., Gaudin, C., Cailmail, S. and Lebrec, D. (1991) Adenosine and hemodynamic alterations in cirrhotic rats. Am. J. Physiol. 260: G543-G547.
41. Chao, T-W., Yu, P-C., Kuo, J-S., Pang, P. K. T. and Yang, M. C. M. (1992) Responsiveness to synthetic parathyroid hormone in the portal vein of portal hypertensive rats. J. Hepatol. 16: 326-331.
42. Chen, G., Yamamoto, Y., Miwa, K. and Suzuki, H. (1991) Hyperpolarisation of arterial smooth muscle induced by endothelial humoural substances. Am. J. Physiol. 260: H1885-H1892.
43. Claria, J., Jimenez, W., Ros, J., Rigol, M., Agneli, P., Arroyo, V., Rivera, F. and Rodes, J. (1994) Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology 20: 1615-1621.
44. Cummings, S. A., Groszmann, R. J. and Kaumann, A. J. (1986) Hypersensitivity of mesenteric veins to 5-hydroxytryptamine-and ketanserin-induced reduction of portal pressure in portal hypertensive rats. Br. J. Pharmacol. 89: 501-513.
45. Duling, B. R., Gore, R. W., Dacey, R. G. and Damon, D. N. (1981) Methods for isolation, cannulation and in vitro study of single microvessels. Am. J. Physiol. 241 (Heart Circ. Physiol. 10): H108-H116.
46. Duncan, G., Johnson, R. H., Lambie, D. G. and Whiteside, E. A. (1980) Evidence of vagal neuropathy in chronic alcoholics. Lancet 2: 1053-1057.
47. Eisenberg, S. (1956) Blood volume in patients with Laennec's cirrhosis of the liver as determined by radioactive chromium-tagged red cells. Am. J. Med. 20: 189-195.
48. Epstein, M., Berk, D. P., Hollenberg, N. K., Adams, D. F., Chalmers, T. C., Abrams, H. L. and Merrill, J. P. (1970) Renal failure in the patient with cirrhosis - the role of active vasoconstriction. Am. J. Med. 49: 175-198.
49. Epstein, M., Loutzenhiser, R., Norsk, P. and Atlas, S. (1989) Relationship between plasma ANF responsiveness and renal sodium handling in cirrhotic humans. Am. J. Nephrol. 9: 133-143.
50. Feng, Q-P., Bergdahl, A., Lu, X-R., Sun, X-Y., Edvinsson, L. and Hedner, T. (1996) Vascular α2-adrenoceptor function is decreased in rats with congestive heart failure. Cardiovasc. Res. 31: 577-584.
51. Fernandez, M., Casadevall, M., Schuligoi, R., Pizcueta, P., Panes, J., Barrachina, M. D., Donnerer, J., Pique, J. M., Esplugues, J. V., Bosch, J., Rodes, J. and Holzer, P. (1994) Neonatal capsaicin treatment does not prevent splanchnic vasodilatation in portal-hypertensive rats. Hepatology 20: 1609-1614.
52. Flanders, S., Hardy, K. I. and Law, M. J. (1996) Effect of cold storage in University of Wisconsin solution on the responses of porcine hepatic arteries to 5-hydroxytryptamine and bradykinin in vitro. Br. J. Pharmacol. 117: 142-146.
53. Forrest, E. H., Jalan, J. and Hayes, P. C. (1996) Review article: renal circulatory changes in cirrhosis - pathogenesis and therapeutic prospects. Aliment. Pharmacol. Ther. 10: 219-231.
54. Gadano, A., Sogni, P., Yang, S., Moreau, R., Bories, P. N. and Lebrec, D. (1996) The changing role of two nitric oxide synthase isoforms during the evolution of two models of portal hypertension. Hepatology 24: 314A.
55. Grose, R. D. and Hayes, P. C. (1992) Review article: the pathophysiology and pharmacological treatment of portal hypertension. Aliment. Pharmacol. Ther. 6: 521-540.
56. Hadoke, P. W. F., Dillon, J. F., John, T. G., Walker, S. W. W., Williams, B. C. and Hayes, P. C. (1996a) Hepatic arteries from cirrhotic patients are not hyporesponsiveness to vasoconstrictors. Hepatology 24: 145A.
57. Hadoke, P. W. F., Dillon, J. F., Walker, S. W., Williams, B. C., John, T. G. and Hayes, P. C. (1996b) Hyporesponsiveness to α-adrenoceptor agonists in cirrhotic patients is not evident when human hepatic and mesenteric arteries are studied in vitro. Br. J. Pharmacol. 117 (Proc. Suppl. 1): 111P.
58. Halversen, J. F. and Myking, A. O. (1974) The porto-systemic collateral pattern in the rat: an angiographic and anatomic study after partial occlusion of the portal vein. Eur. Surg. Res. 6: 183-195.
59. Hartleb, M., Moreau, R., Gaudin, C. and Lebrec, D. (1995) Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis. J. Hepatol. 22: 202-207.
60. Heinemann, A. and Stauber, R. E. (1995) The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats. Eur. J. Pharmacol. 278: 87-90.
61. Heinemann, A. and Stauber, R. E. (1996) Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats. J. Hepatol. 24: 739-746.
62. 1-Adrenergic vascular reactivity is reduced in isolated rings of the hepatic artery and the portal vein from patients with liver cirrhosis. Hepatology 24: 205A.
63. Hori, N. and Groszmann, R. J. (1996a) Hyporeactivity to vasoconstrictors but not basal differences in perfusion pressure can be explained by increased nitric oxide synthesis in mesenteric arterial beds of portal hypertensive rats. Hepatology 24: 313A.
64. Hori, N. and Groszmann, R. J. (1996b) Direct evidence for increased functional activity of eNOS in superior mesenteric arterial (SMA) beds of portal hypertensive rats. Hepatology 24: 314A.
65. Hori, N., Takahashi, H., Okanoue, T., Sawa, Y., Mori, T., Takami, S., Yoshimoro, M. and Kashima, K. (1995) Augmented endogenous nitric oxide production in partial portal vein ligated rats. Clin. Exp. Pharmacol. Physiol. 22: 506-511.
66. Hou, M-C., Zhang, S., Redmond, E. M., Cahill, P. A. and Sitzmann, J. V. (1996) Effect of chronic nitric oxide synthase and cyclooxygenase blockade on splanchnic haemodynamics in portal hypertensive rats. Hepatology 24: 315A.
67. Huang, Y.-T., Lo, J-W., Lin, H.-C., Tsai, Y.-T., Hong, C.-Y. and Yang, M. C.-M. (1995a) Change in vascular cAMP and cGMP contents in portal hypertensive rats. Pharmacology 50: 86-91.
68. Huang, Y.-T., Yu, P.-C., Lee, M.-F., Lin, H.-C., Hong, C.-Y. and Yang, M. C.-M. (1995b) Decreased vascular contractile and inositol phosphate responses in portal hypertensive rats. Can. J. Physiol. Pharmacol. 73: 378-382.
69. Huang, Y.-T., Lin, H.-C., Yu, P.-C., Lee, F.-Y., Tsai, Y.-T., Lee, S.-D. and Yang, M. C.-M. (1996) Decreased vascular reactivity of portal veins in rats with portal hypertension. J. Hepatol. 24: 194-199.
70. Jacob, G., Bishara, B., Lee, S. S., Hilzenart, N. and Bomzon, A. (1991) Cardiovascular responses to serotonin in experimental liver disease. Hepatology 14: 1235-1242.
71. Jalan, R., Newby, D. E., Masumori, S., Hayes, P. C., Boon, N. A. and Webb, D. J. (1996) Impaired central but stimulated humoural regulation of vascular tone in patients with cirrhosis and ascites. Hepatology 24: 451A.
72. Jensen, L. S., Juhl, C. O. and Mulvany, M. J. (1987) Mechanical, morphological and pharmacological properties of oesophageal varices and small mesenteric veins in portal hypertensive rabbits. Acta Physiol. Scand. 130: 649-656.
73. Jimenez, W. (1995) Acetylcholine-induced vasorelaxation in portal hypertensive rats. Reply. Hepatology 22: 1010-1011.
74. Johansson, B. (1976) Structural and functional changes in rat portal veins after experimental portal hypertension. Acta Physiol. Scand. 98: 381-383.
75. Kanwar, S., Kubes, P., Tepperman, B. L. and Lee, S. S. (1996) Nitric oxide synthase activity in portal-hypertensive and cirrhotic rats. J. Hepatol. 25: 85-89.
76. Karatapanis, S., McCormick, P. A., Kakad, S., Chin, J. K. T., Islam, M., Jeremy, J., Harry, D., McIntyre, N., Burroughs, A. K. and Jacobs, M. (1994) Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats. Hepatology 20: 1516-1521.
77. Kaumann, A. J. and Groszmann, R. J. (1989) Catecholamines relax portal and mesenteric veins from normal and portal hypertensive rats. Am. J. Physiol. 257 (Gastrointest. Liver Physiol. 20): G977-G981.
78. 2 receptors and lowers portal pressure in portal hypertensive rats. Gastroenterology 95: 1601-1606.
79. Komeichi, H., Moreau, R., Cailmail, S., Gaudin, C. and Lebrec, D. (1994) Haemodynamic responses to selective blockade of β2- and β1-adrenoceptors in conscious rats with cirrhosis. J. Hepatol. 21: 779-786.
80. Kontos, H. A., Shapiro, W., Mauck, H. P. and Patterson, J. L. (1964) General and regional circulatory alterations in cirrhosis of the liver. Am. J. Med. 37: 526-534.
81. Koppel, M. H., Coburn, J. W., Mims, M. M., Goldstein, H., Boyle, J. D. and Rubine, M. E. (1969) Transplantation of cadaveric kidneys from patients with hepatorenal syndrome: evidence for the functional nature of renal failure in advanced liver disease. N. Engl. J. Med. 289: 1155-1159.
82. Laragh, J. H., Cannon, P. J., Bentzel, C. J., Sickinski, A. M. and Meltzer, J. I. (1963) Angiotensin II, norepinephrine and renal transport of electrolytes and water in normal man and in cirrhosis with ascites. J. Clin. Invest. 42: 1179-1192.
83. Lee, S. S. and Sharkey, K. A. (1993) Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats. Am. J. Physiol. 264 (Gastrointest. Liver Physiol. 27): G868-G873.
84. Lee, S. S., Marty, J., Mantz, J., Samain, E., Braillon, A. and Lebrec, D. (1990) Desensitisation of myocardial β-adrenergic receptors in cirrhotic rats. Hepatology 12: 481-485.
85. Lee, S. S., Chilton, E. L. and Pak, J-M. (1992) Adenosine receptor blockade reduces splanchnic hyperemia in cirrhotic rats. Hepatology 15: 1107-1111.
86. Lee, S. S., Pak, J-M., Medlicott, S. M. and Bomzon, A. (1995) Vasodilatory responses of isolated arteries of cirrhotic rats. Clin. Sci. 89: 227-232.
87. Leehey, D. J. (1993) Dissociation between pressor sensitivity in vivo and contractile reactivity in vivo to angiotensin II in rats with experimental cirrhosis. Clin. Sci. 84: 525-529.
88. Leehey, D. J., Daugirdas, J. T., King, T. S., Stanley, M. M. and Betzelos, S. J. (1985) Pressor sensitivity to angiotensin II and phenylephrine in cirrhotic rats. Gastroenterology 88: 1674.
89. Lenz, K., Hortnagl, H., Magometschigg, D., Kleinberger, G., Druml, W. and Langner, A. (1985) Function of the autonomic nervous system in patients with hepatic encephalopathy. Hepatology 5: 831-836.
90. 1-adrenoceptors of portal hypertensive rats. Br. J. Pharmacol. 111: 439-444.
91. Lieberman, F. L. and Reynolds, T. B. (1967) Plasma volume in cirrhosis of the liver: its relation to portal hyertension, ascites and renal failure. J. Clin. Invest. 46: 1297-1308.
92. 4/phenobarbital model of experimental liver cirrhosis in rats. In: The Kidney in Liver Disease, 3rd edn., pp. 305-327, Epstein, M. (ed.) Williams and Wilkins, Baltimore.
93. Loyke, H. I. and Hoobler, S. W. (1982) Presence of a circulating depressor substance in rat cross perfusion after chronic CCl4-treatment. Pharmacol. Res. Commun. 14: 621-627.
94. Lu, J-L., Schmiege, L. M., Kuo, L. and Liao, J. C. (1996) Down-regulation of ecNOS by lipopolysaccharide. Biochem. Biophys. Res. Commun. 225: 1-5.
95. Lunzer, M. R., Manghani, K. K., Newman, S. P., Sherlock, S. P. V., Bernard, A. G. and Ginsberg, J. (1975) Impaired cardiovascular responsiveness in liver disease. Lancet ii: 382-385.
96. MacGilchrist, A. J. and Reid, J. L. (1990) Impairment of autonomic reflexes in cirrhosis. Am. J. Gastroenterol. 85: 288-292.
97. MacGilchrist, A. J., Sumner, D. and Reid, J. L. (1991) Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular defect. Hepatology 13: 689-694.
98. Malmquist, U. and Arner, A. (1988) Contractile properties during development of hypertrophy of the smooth muscle in the rat portal vein. Acta Physiol. Scand. 133: 49-61.
99. Mankad, P. S., Slavik, Z. and Yacoub, M. (1992) Endothelial dysfunction caused by University of Wisconsin preservative solution in the rat heart: the importance of temperature. J. Thorac. Cardiovasc. Surg. 104: 1618-1624.
100. Martin, V., Wiesel, M-L., Albert, A. and Beretz, A. (1995) Thrombin does not alter vascular hyporeactivity in models of endotoxin-induced septic shock in rats. Clin. Sci. 88: 149-157.
101. Martinez-Cuesta, M. A., Moreno, L., Pique, J. M., Bosch, J., Rodrigo, J. and Espluggues, J. V. (1996) Nitric oxide-mediated ß2-adrenoceptor relaxation is impaired in mesenteric veins from portal hypertensive rats. Gastroenterology 111: 727-735.
102. Martini, G. A., Arndt, H., Baltzer, G., Buchta, I., Hardewig, A., Marsch, W. and Schmidt, H. A. (1970) Pulmonary circulation in portal hypertension. Ann. NY Acad. SCi. 170: 280-295.
103. Mathie, R. T., Ralevic, V., Moore, K. P. and Burnstock, G. (1992) The role of nitric oxide in the mesenteric vascular bed of cirrhotic rats. Hepatology 16: 116A.
104. Mathie, R. T., Ralevic, V., Moore, K. P. and Burnstock, G. (1996) Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide? Hepatology 23: 130-136.
105. McNally, P. C., Watt, P. A. C., Rimmer, T., Burden, A. C., Hearnshaw, J. R. and Thurston, M. (1994) Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin. Sci. 87: 31-36.
106. Michielsen, P. P., Boeckxstaens, G. E., Sys, S. U., Herman, A. G. and Pelckmans, P. A. (1995a) The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats. J. Hepatol. 23: 341-347.
107. Michielsen, P. P., Boeckxstaens, G. E., Sys, S. U., Herman, A. G. and Pelckmans, P. A. (1995b) Role of nitric oxide in hyporeactivity of isolated aortic rings in portal hypertensive rats. Eur. J. Pharmacol. 273: 167-174.
108. Michielsen, P. P., Boeckxstaens, G. E., Sys, S. U., Herman, A. G. and Pelckmans, P. A. (1995c) Aminoguanidine reverses thoracic aortic hyporeactivity to norepinephrine in portal vein ligated rats. Gastroenterology 108: A112.
109. Michielsen, P. P., Boeckxstaens, G. E., Sys, S. U., Herman, A. G. and Pelckmans, P. A. (1995d) Acetylcholine-induced vasorelaxation in portal hypertensive rats. Hepatology 22: 1009-1010.
110. Morales, M., Jimenez, W., Ros, J., Leivas, A., Perez-Sala, D., Lamas, S., Arroyo, V., Rivera, F. and Rodes, J. (1995) Transcriptional activation of inducible nitric oxide synthase in arterial vessels of cirrhotic rats. Hepatology 22: 155A.
111. Moreau, R. and Lebrec, D. (1995) Endogenous factors involved in the control of arterial tone in cirrhosis. J. Hepatol. 22: 370-376.
112. Moreau, R., Komeichi, H., Kirstetter, P., Ohsuga, M., Cailmail, S. and Lebrec, D. (1994) Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis. Gastroenterology 106: 1016-1023.
113. Moreno, L., Martinez-Cuesta, M. A., Pique, J. M., Bosch, J. and Esplugues, J. V. (1996) Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats. Naunyn Schmiederbergs Arch. Pharmacol. 354: 474-480.
114. Morgan, T. R., Morgan, K., Jonas, G. M. and Thillainadarajah, I. (1992) Atrial natriuretic factor in experimental cirrhosis in rats. Gastroenterology 102: 1356-1362.
115. Mulvany, M. J. and Aalkjaer, C. (1990) Structure and function of small arteries. Am. J. Physiol. 70: 921-961.
116. Mulvany, M. J. and Halpern, W. (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41: 19-26.
117. Murray, B. M. and Paller, M. S. (1985) Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action. Circ. Res. 57: 424-431.
118. Murray, J. F., Dawson, A. M. and Sherlock, S. (1958) Circulatory changes in chronic liver disease. Am. J. Med. 24: 358-367.
119. Nicholls, K. M., Shapiro, M. D., Van Putten, V. J., Kluge, R., Chung, H-M., Bichet, D. G. and Schrier, R. W. (1985) Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates and suppressibility by central blood volume expansion. Circ. Res. 56: 457-461.
120. Niederberger, M., Gines, P., Tsai, P., Martin, P. Y., Morris, K., Weigert, A., McMurty, I. and Schrier, R. W. (1995) Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in arterial vasodilatation in cirrhosis. Hepatology 21: 1625-1631.
121. Niederberger, M., Gines, P., Martin, P. Y., Tsai, P., Morris, K., McMurty, I. and Schrier, R. W. (1996) Comparison of vascular nitric oxide production and systemic haemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 24: 947-951.
122. Oberti, F., Sogni, P., Cailmail, S., Moreau, R., Pipy, B. and Lebrec, D. (1993) Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension. Hepatology 18: 621-627.
123. Ohsuga, M., Moreau, R., Hartleb, M., Komeichi, H. and Lebrec, D. (1994) Blunted systemic, splanchnic, and renal haemodynamic responses to atrial natriuretic peptide in rats with cirrhosis. J. Hepatol. 20: 91-96.
124. Pak, J-M. and Lee, S. S. (1993) Vasoactive effects of bile salts in cirrhotic rats: in vivo and in vitro studies. Hepatology 18: 1175-1181.
125. Pak, J-M. and Lee, S. S. (1994) Review. Glucagon in portal hypertension. J. Hepatol. 20: 825-832.
126. Pizcueta, P., Pique, J. M., Fernandez, M., Bosch, J., Rodes, J., Whittle, B. J. R. and Moncada, S. (1992) Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 103: 1909-1915.
127. Plane, F. and Garland, C. J. (1996) Special report. Influence of contractile agonists on the mechanisms of endothelium-dependent relaxation in rat isolated mesenteric artery. Br. J. Pharmacol. 119: 191-193.
128. Procter, E. and Chatamra, K. (1982) High yield micronodular cirrhosis in the rat. Gastroenterology 83: 1183-1190.
129. Rahman, S. N., Abraham, W. T. and Schrier, R. W. (1992) Peripheral arterial vasodilatation hypothesis in cirrhosis. Gastroenterol. Int. 5: 192-195.
130. Ralevic, V., Mathie, R. T., Moore, K. P. and Burnstock, G. (1996) Vasoconstrictor responsiveness of the rat mesenteric arterial bed in cirrhosis. Br. J. Pharmacol. 118: 435-441.
131. Robinson, N. M. K., Smith, R. E. A., McPeake, J. R., Martin, J. F., Williams, R. and Mocada, S. (1995) Induction of nitric oxide synthase in the hepatic artery during hepatic failure in man. Gut 36 (Suppl. 1): A19.
132. Ros, J., Jimenez, J., Lamas, S., Claria, J., Arroyo, V., Rivera, F. and Rodes, J. (1995) Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology 21: 554-560.
133. Rothe, C. F. (1983) Venous system: physiology of the capacitance vessels. In: Handbook of Physiology, Section 2, The Cardiovascular System, Vol. III, Peripheral Circulation and Organ Blood Flow, Pt. 1, Ch. 13, pp. 397-452, Geiger, S. R., Sheperd, J. T., and Abboud, F. M. (eds.) American Physiology Society, Bethesda.
134. Rubin, E. and Lieber, C. S. (1974) Fatty liver, alcoholic hepatitis and cirrhosis produced by alcohol in primates. N. Engl. J. Med. 290: 128-135.
135. Ryan, J., Sudhir, K., Jennings, G., Esler, M. and Dudley, F. (1993) Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis. Gastroenterology 105: 1167-1172.
136. Ryan, J., Jennings, G., Dudley, F. and Chin-Dusting, J. (1996) Smooth muscle-derived nitric oxide is elevated in isolated forearm veins in human alcoholic cirrhosis. Clin. Sci. 91: 23-28.
137. Schneider, F., Lutun, P., Boudjema, K., Wolf, P. and Tempe, J-D. (1994) In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. Hepatology 19: 38-44.
138. Schrier, R. W. and Caramelo, C. (1988) Haemodynamic and hormonal alterations in hepatic cirrhosis. In: The Kidney in Liver Disease, 3rd edn., Ch. 11, pp. 265-285, Epstein, M. (ed.) Williams and Wilkins, Baltimore.
139. Schrier, R. W., Arroyo, V., Bernardi, M., Epstein, M., Henriksen, J. H. and Rodes, J. (1988) Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8: 1151-1157.
140. Schroeder, E. T., Anderson, G. H., Goldman, S. H. and Streeten, D. H. P. (1976) Effect of blockade of AII on blood pressure, renin and aldosterone in cirrhosis. Kidney Int. 9: 511-519.
141. Sieber, C. C. and Groszmann, R. J. (1991a) Hyporeactivity to norepinephrine, AVP and KC1 in resistance vessels of portal hypertensive rats. Hepatology 14: 122A.
142. Sieber, C. C. and Groszmann, R. J. (1991b) Hyporeactivity to methoxamine in mesenteric resistance vessels of portal hypertensive rats. Reversal by blockade of NO formation. Hepatology 14: 122A.
143. Sieber, C. C. and Groszmann, R. J. (1992a) Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 103: 235-239.
144. Sieber, C. C. and Groszmann, R. J. (1992b) In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am. J. Physiol. 262: G996-G1001.
145. Sieber, C. C., Lopez-Talavera, J. C. and Groszmann, R. J. (1993) Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 104: 1750-1754.
146. Sieber, C. C., Lee, F. Y. and Groszmann, R. J. (1996) Long-term octreotide treatment prevents vascular hyporeactivity in portal hypertensive rats. Hepatology 23: 1218-1223.
147. Sitzmann, J. V., Li, S-S. and Lin, P-W. (1989) Prostacyclin mediates vascular response to norepinephrine in portal hypertension. J. Surg. Res. 47: 208-211.
148. Sitzmann, J. V., Li, S-S., Wu, Y., Groszmann, R. and Bulkley, G. B. (1990) Decreased mesenteric vascular response to angiotensin II in portal hypertension. J. Surg. Res. 48: 341-344.
149. Sitzmann, J. V., Campbell, K., Wu, Y. and St. Clair, C. (1994) Prostacyclin production in acute, chronic, and long-term experimental portal hypertension. Surgery 115: 290-294.
150. Sitzmann, J. V., Wu, Y., Aguilera, G., Cahill, P. A. and Burns, R. C. (1995) Loss of angiotensin II receptors in portal hypertensive rabbits. Hepatology 22: 559-564.
151. Smith, R. E. A., McPeake, J. R., Gimson, A. E. S., Martin, J. F., Williams, R. and Moncada, S. (1993a) Nitric oxide and the haemodynamic changes in hepatic failure. Gut 34: S20.
152. Smith, R. E. A., McPeake, J. R., Gimson, A. E. S., Williams, R., Martin, J. F. and Moncada, S. (1993b) Nitric oxide and the haemodynamic changes in hepatic failure. Endothelium 1 (Suppl): S90.
153. Sogni, P., Sabry, S., Moreau, R., Gadano, A., Lebrec, D. and Dinh-Xuan, A. T. (1996) Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats. J. Hepatol. 24: 487-490.
154. Sumner, D. J., Elliot H. L. and Reid, J. L. (1982) Analysis of the pressor dose response. Clin. Pharmacol. Ther. 32: 450-458.
155. Tsuchida, S., Hiraoka, M., Sudo, M., Kigoshi, S. and Muramatsu, I. (1994) Attenuation of sodium nitroprusside responses after prolonged incubation of rat aorta with endotoxin. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H2035-H2310.
156. Tsukamoto, H., Matsuoka, M. and French, S. W. (1990) Experimental models of hepatic fibrosis. Sem. Liv. Dis. 10: 56-65.
157. Vallance, P. and Moncada, S. (1991) Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 337: 776-778.
158. Vanhoutte, P. M. and Miller, V. M. (1985) Heterogeneity of endothelium-dependent responses in mammalian blood vessels. J. Cardiovasc. Pharmacol. 7 (Suppl. 3), S12-S23.
159. Van Obbergh, L., Vallieres, Y. and Blaise, G. (1996) Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J. Hepatol. 24: 747-752.
160. Villamediana, L. M., Dieguez, G., Santos, J. C., Garcia-Villalon, L. G., Caramelo, C. and Lopez-Novoa, J. M. (1988) Vascular reactivity in rats with cirrhosis of the liver. Can. J. Physiol. Pharmacol. 66: 567-572.
161. Villamediana, L. M., Garcia-Villalon, L. G., Caramelo, C. and Lopez-Novoa, J. M. (1989) Effect of dietary sodium intake on the pressor reactivity to angiotensin II in rats with experimental cirrhosis of the liver. Can. J. Physiol. Pharmacol. 67: 1506-1511.
162. Vorobioff, J., Bredfeldt, J. and Groszmann, R. J. (1984) Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 87: 1120-1126.
163. 1-adrenergic receptor-mediated smooth muscle contraction in aorta from endotoxic rats. Life Sci. 45:509-515.
164. Weigert, A. L., Martin, P-Y., Niederberger, M., Higa, E. M. S., McMurty, I. E, Gines, P. and Schrier, R. W. (1995) Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology 22: 1856-1862.
165. Willet, I., Esler, M., Burke, F., Leonard, P. and Dudley, F. (1985) Total and renal sympathetic nervous system activity in alcoholic cirrhosis. J. Hepatol. 1: 639-648.
166. Woods, R. P., Ellis, D. and Starzl, T. E. (1987) The reversal of the hepatorenal syndrome in four paediatric patients following successful orthotopic liver transplantation. Ann. Surg. 205: 415-419.
167. Wu, Y., Li, S. S., Campbell, K. A. and Sitzmann, J. V. (1991) Modulation of splanchnic vascular sensitivity to angiotensin II. Surgery 110: 162-168.
168. Wyke, R. J. (1989) Bacterial infections complicating liver disease. Baillieres Clin. Gastroenterol. 3: 187-210.
169. Zern, M. A., Saber, A. and Shafritz, D. A. (1983) Molecular mechanisms for changes in hepatic protein synthesis produced by schistosomiasis infection in mice. Biochemistry 22: 6072-6077.